Nestle to buy medical device company Phagenesis in stages

ZURICH, Sept 1 (Reuters) - Nestle on Thursday

announced a deal to buy Phagenesis, a British medical device

company working on a new treatment for dysphagia, a condition

where patients are unable to swallow safely.

Read more